(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

C

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

C

ST13

US500000090322340

Class

5, 42, 44

Filing

90322340

Registration

6454659

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

08/17/2026

Trademark type

Combined

Nice classes

5, 42, 44

Filing date

11/16/2020

Registration date

08/17/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/17/2021

Last transaction

08/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

12/02/2009

First use in commerce

12/02/2009

Drawing code

5

Owner type

16

Owner location

Rye Brook, NY, US

Examiner

BATT, JAIME L

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of stylized version of the letter "C".

Holders and representatives

Holders

Curemark, LLC

Representatives

Nicole K. McLaughlin DUANE MORRIS LLP

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substances for the diagnosistreatment and prevention of viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of InfluenzaCoronavirusespancreatic deficienciesgastrointestinal diseaseinternal malabsorption syndromesAutismAutism Spectrum DisorderAttention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterialantiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders

Class 42

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; Development of pharmaceuticals and medical devices for others; Providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseasesspecifically baseline stagingdata gathering and monitoring of earlymiddle and late stage neurological diseases; Design and development of medical assays for others; clinical research and development of treatments for viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of InfluenzaCoronavirusespancreatic deficienciesgastrointestinal diseaseinternal malabsorption syndromesAutismAutism Spectrum DisorderAttention Deficit Hyperactivity Disorder and Williams Syndrome; clinical research and development of treatments for antibacterialantiviralantifungal preparations for skin and wound healing; clinical research and development of disinfectantsantiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body

Class 44

Medical testing for diagnostic and treatment purposes; Medical consultations; medical testing for diagnostic treatment purposes in the fields of viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of InfluenzaCoronavirusespancreatic deficienciesgastrointestinal diseaseinternal malabsorption syndromesAutismAutism Spectrum DisorderAttention Deficit Hyperactivity Disorder and Williams Syndrome; Medical diagnostic testingmonitoring and reporting services; performing diagnosis of diseases; Health care servicesthe administration of medical assays for the detection of enzymes in humans

Publications

History of USPTO decisions and trademark events.

14 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/17/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

08/17/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/01/2021

PUBO

PUBLISHED FOR OPPOSITION

06/01/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/12/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/03/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/03/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/03/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/03/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/27/2021

DOCK

ASSIGNED TO EXAMINER

04/26/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/15/2021

NWAP

NEW APPLICATION ENTERED

11/19/2020

Continuous trademark protection

Get notified about every new filing that threatens C or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.